Double immunofluorescence analysis confirmed that CD45+ immune cells in S100a4−/− gliomas did not express S100A4, although S100A4 is expressed in a subset of glioma cells (Fig. 6f, Supplementary Fig. 9e). Here, PTPRC is linked to central nervous system cancer.